✦ LIBER ✦

A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancer

✍ Scribed by Naeim, Arash; Ward, Peter R.; Wang, Hei-Jing; Dichmann, Richard; Liem, Andre K.D.; Chan, David; Patel, Ravi; Hu, Edward H.L.; Tchekmedyian, Neres S.; Wainberg, Zev A.; Hecht, J. Randolph

Book ID: 122366276
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 233 KB
Volume: 4
Category: Article
ISSN: 1879-4068
DOI: 10.1016/j.jgo.2013.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine, irinot

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Capecitabine and bevacizumab as first-li

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

Phase II Trial of Erlotinib and Capecita

Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Peter Kozuch; Steve Malamud; Carrie Wasserman; Peter Homel; Takhir Mirzoyev; Mic 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

A Phase II Study of Capecitabine, Oxalip

A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study

✍ Efrat Dotan, Neal J. Meropol, Barbara Burtness, Crystal S. Denlinger, James Lee, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 212 KB

133 A phase II study of oxaliplatin, cap

133 A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer

✍ N. Fernando; M. Morse; G. Blobe; L. Sutton; L. Odogwu; W. Honeycutt; M. Bauer; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB